共 5 条
[3]
Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report
[J].
WORLD JOURNAL OF CLINICAL ONCOLOGY,
2019, 10 (10)
:350-357
[5]
Zattra E, 2014, GIORN ITAL DERMAT V, V149, P395